Entera Bio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016
Market Capitalization	71	17	21	81	20	26	35	-	-
Market Cap Growth	-	-17.80%	-74.04%	308.59%	-23.75%	-24.94%	-	-	-
Enterprise Value	60	7	9	56	12	11	23	-8	11
PE Ratio	-1.94	-1.94	-1.61	-6.65	-1.77	-2.41	-3.36	-	-
PS Ratio	-	-	156.95	141.91	54.33	110.21	69.31	-	-
PB Ratio	6.83	1.67	1.79	3.59	2.64	2.18	3.43	-	-
P/FCF Ratio	-2.36	-2.36	-1.68	-8.92	-1.87	-2.90	-3.51	-	-
P/OCF Ratio	-2.37	-2.37	-1.68	-8.94	-1.88	-2.92	-3.54	-	-
EV/Sales Ratio	-	-	65.77	98.84	31.97	47.13	46.26	-	-
EV/EBITDA Ratio	-0.76	-0.76	-0.68	-4.63	-1.05	-1.05	-2.26	0.70	-9.07
EV/EBIT Ratio	-0.75	-0.75	-0.68	-4.61	-1.04	-1.03	-2.24	0.70	-8.80
EV/FCF Ratio	-0.91	-0.91	-0.70	-6.22	-1.10	-1.24	-2.35	1.72	-3.32
Debt / Equity Ratio	0.04	0.04	0.01	0.01	0.06	0.03	-	-0.12	-0.58
Debt / EBITDA Ratio	-0.04	-0.04	-0.01	-0.02	-0.04	-0.03	-	-0.35	-12.65
Debt / FCF Ratio	-0.05	-0.05	-0.01	-0.03	-0.04	-0.03	-	-0.85	-4.62
Quick Ratio	10.10	10.10	9.36	7.93	4.81	3.37	3.88	5.81	0.39
Current Ratio	10.32	10.32	9.58	8.01	4.95	3.41	3.95	6.15	0.52
Asset Turnover	0	0	0.01	0.02	0.03	0.02	0.04	0	-
Return on Equity (ROE)	-101.80%	-101.80%	-82.90%	-59.80%	-147.10%	-143.50%	96.10%	39.40%	-
Return on Assets (ROA)	-83.90%	-83.90%	-74.60%	-47.50%	-99.40%	-97.10%	-77.40%	-114.50%	-
Return on Capital (ROIC)	-82.96%	-82.96%	-110.33%	-53.63%	-140.62%	-93.75%	-107.36%	41.00%	50.99%
Earnings Yield	-12.53%	-51.42%	-62.15%	-15.04%	-56.56%	-41.50%	-29.73%	-	-
FCF Yield	-10.33%	-42.38%	-59.65%	-11.21%	-53.50%	-34.45%	-28.47%	-	-
Buyback Yield / Dilution	-0.69%	-0.69%	-10.23%	-41.90%	-51.62%	-52.15%	-77.78%	33.53%	-
Total Shareholder Return	-0.69%	-0.69%	-10.23%	-41.90%	-51.62%	-52.15%	-77.78%	33.53%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).